ERNA
Ernexa Therapeutics Inc.
-0.06 (-1.66%)3.85USD17.9K成交股數6.3M市值0.1本益比(近四季)10.8股價營收比–營收年增(近四季)–下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | – | – | – | – | – | – | 487K+855% | 47K | 47K | – | 51K | – |
| 營業成本 | 0.00 | – | – | – | 0.00 | – | −60K | 95K | 61K | – | 120K | – |
| 毛利 | – | – | – | – | – | – | 547K-893% | −48K | −14K | – | −69K | – |
| 毛利率 | – | – | – | – | – | – | 112.3% | -102.1% | -29.8% | – | -135.3% | – |
| 研發費用 | 2.8M | 1.9M | 676K | 1.0M | 1.1M | 1.3M | 1.0M | 987K | 1.5M | 1.4M | 1.4M | 1.5M |
| 銷售管理費用 | 1.3M | 1.6M | 1.4M | 958K | 1.4M | 1.4M | 3.4M | 3.9M | 4.3M | 4.4M | 4.0M | 2.6M |
| 營業利益 | −4.1M+64% | −5.6M+105% | −2.1M-7% | −2.0M-60% | −2.5M-57% | −2.7M-53% | −2.3M-59% | −4.9M+8% | −5.8M | −5.8M | −5.5M | −4.5M |
| 營業利益率 | – | – | – | – | – | – | -463.9% | -10,491.5% | -12,312.8% | – | -10,794.1% | – |
| 稅後淨利 | −4.0M+28% | −5.5M-33% | −1.5M-94% | −1.2M-78% | −3.1M-53% | −8.2M+33% | −26.6M+376% | −5.5M+23% | −6.6M | −6.2M | −5.6M | −4.5M |
| 淨利率 | – | – | – | – | – | – | -5,462.8% | -11,763.8% | -14,142.6% | – | -10,962.7% | – |
| 稀釋 EPS | -3.40-78% | -6.95-88% | 70.86-196% | -0.15-99% | -15.19+1135% | -57.76+4967% | -73.70+7055% | -15.34+1705% | -1.23 | -1.14 | -1.03 | -0.85 |
| 稀釋股數 | 1.2M | 792K | 6.3M | 8.2M | 207K | 142K | 361K | 361K | 5.4M | 5.3M | 5.4M | 5.3M |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 5.0M | 9.2M | 1.9M | 3.0M | 4.3M | 1.9M | 4.3M | 2.6M | 5.1M | 7.6M | 4.6M | 1.8M |
| 應收帳款 | – | – | – | – | – | – | – | – | – | – | – | – |
| 存貨 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總資產 | 6.3M | 10.5M | 5.8M | 6.2M | 7.6M | 5.1M | 7.7M | 46.5M | 49.7M | 49.1M | 52.2M | 47.0M |
| 有息負債 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總負債 | 3.1M | 3.7M | 3.4M | 2.6M | 3.1M | 11.0M | 53.1M | 55.0M | 53.1M | 46.9M | 48.7M | 43.1M |
| 股東權益 | 3.2M | 6.9M | 2.4M | 3.6M | 4.4M | −6.0M | −45.4M | −8.5M | −3.4M | 2.2M | 3.6M | 3.9M |
| 負債比 | 49.3% | 34.9% | 58.8% | 42.2% | 41.4% | 217.6% | 688.1% | 118.3% | 106.9% | 95.5% | 93.2% | 91.8% |
| 淨現金(現金 − 有息負債) | – | – | – | – | – | – | – | – | – | – | – | – |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | −2.3M+10% | – | – | – | −2.1M | – | – | −3.7M | – | – | – |
| 資本支出 | – | 2K | – | – | – | – | – | – | 101K | – | – | – |
| 自由現金流 | – | −2.3M | – | – | – | – | – | – | −3.8M | – | – | – |
| 折舊攤銷 | 100K | 8K | −553K | 100K | 500K | 18K | 100K | 100K | 39K | – | – | – |
| 買回庫藏股 | – | – | – | – | – | – | – | – | – | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | – | – | – | – | – | – | – | -8,187.2% | – | – | – |
營收拆解 2020 年度 10-K 的分部揭露 · 年增對前一年度
產品／服務2020 年度 · 5.8M
| Subscription Revenue | 4.9M | 84.2% | -65.8% |
|---|---|---|---|
| Other Revenue | 492K | 8.5% | -84.5% |
| Hardware Revenue | 426K | 7.3% | -81.9% |
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | – | – | −14.1M | –% | -2.24 | −7.1M |
| FY2024 | 582K | +755.9% | −44.5M | -7,652.7% | -48.96 | −16.2M |
| FY2023 | 68K | – | −21.7M | -31,864.7% | -4.08 | −20.4M |
| FY2022 | 0.00 | – | −24.6M | –% | -8.06 | −21.3M |
| FY2021 | – | – | −123M | –% | -56.61 | −23.6M |
| FY2020 | 5.8M | -70.7% | −7.3M | -125.7% | -0.41 | −8.1M |
| FY2019 | 19.8M | -15.1% | −2.0M | -10.3% | -0.72 | 2.6M |
| FY2018 | 23.3M | – | −259K | -1.1% | -0.10 | 717K |